Oxcarbazepine Suspension
Product Images NDC 72888-074

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72888-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Oxcarbazepine 300 mg/5 mL Oral Suspension (NDC 72888-074-14)

Oxcarbazepine 300 mg/5 mL Oral Suspension (NDC 72888-074-14)
Oxcarbazepine Oral Suspension is a medication used for oral use only that comes in a 250 mL bottle, and each 5 mL contains 300 mg of oxcarbazepine. The medication guide should be printed from www_advagenpharma.com/medguide/oxcarbazepine suspension and dispensed separately to each patient. The medication should be stored in the original container at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The drug should be used within 7 weeks of first opening the bottle. Before taking the drug, one should shake it well. The package insert and enclosed oxcarbazepine oral suspension instruction sheet outline the appropriate dosage. Users are advised to keep the drug out of the reach of children.*
FDA Label Image

Oxcarbazepine Chemical Structural. (Oxcarbazepine Oral Susp Chemical Structural)

Oxcarbazepine Chemical Structural. (Oxcarbazepine Oral Susp Chemical Structural)
FDA Label Image

Oxcarbazepine 300 mg/5 mL Oral Suspension (NDC 72888-074-14)

Oxcarbazepine 300 mg/5 mL Oral Suspension (NDC 72888-074-14)
Each 5 ml of the product contains 300 mg of oxcarbazepine. The enclosed instruction sheet should be consulted for dosage, and the original container should be used for storage. The product should be stored at a temperature between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F) as specified by USP Controlled Room Temperature. The product must be used within 7 weeks of the first opening of the bottle. It is important to keep this and all medications out of reach of children. The medication guide must be dispensed to each patient separately. The product has a volume of 250 mL and is distributed by Advagen Pharma Limited.*
FDA Label Image

Oxcarbazepine Oral Susp Figure 1. (Oxcarbazepine Oral Susp Fig 1)

Oxcarbazepine Oral Susp Figure 1. (Oxcarbazepine Oral Susp Fig 1)
FDA Label Image

Oxcarbazepine Oral Susp Fig-1a (Oxcarbazepine Oral Susp Fig 1a)

Oxcarbazepine Oral Susp Fig-1a (Oxcarbazepine Oral Susp Fig 1a)
FDA Label Image

Oxcarbazepine Oral Susp Fig-1b (Oxcarbazepine Oral Susp Fig 1b)

Oxcarbazepine Oral Susp Fig-1b (Oxcarbazepine Oral Susp Fig 1b)
FDA Label Image

Oxcarbazepine Oral Susp Fig-1c (Oxcarbazepine Oral Susp Fig 1c)

Oxcarbazepine Oral Susp Fig-1c (Oxcarbazepine Oral Susp Fig 1c)
FDA Label Image

Oxcarbazepine Oral Susp Figure 2. (Oxcarbazepine Oral Susp Fig 2)

Oxcarbazepine Oral Susp Figure 2. (Oxcarbazepine Oral Susp Fig 2)
FDA Label Image

Oxcarbazepine Oral Susp Fig-2a (Oxcarbazepine Oral Susp Fig 2a)

Oxcarbazepine Oral Susp Fig-2a (Oxcarbazepine Oral Susp Fig 2a)
FDA Label Image

Oxcarbazepine Oral Susp Fig-2b (Oxcarbazepine Oral Susp Fig 2b)

Oxcarbazepine Oral Susp Fig-2b (Oxcarbazepine Oral Susp Fig 2b)
FDA Label Image

Oxcarbazepine Oral Susp Fig-2c (Oxcarbazepine Oral Susp Fig 2c)

Oxcarbazepine Oral Susp Fig-2c (Oxcarbazepine Oral Susp Fig 2c)
FDA Label Image

Oxcarbazepine Oral Susp Figure 3. (Oxcarbazepine Oral Susp Fig 3)

Oxcarbazepine Oral Susp Figure 3. (Oxcarbazepine Oral Susp Fig 3)
FDA Label Image

Oxcarbazepine Oral Susp Fig-3a (Oxcarbazepine Oral Susp Fig 3a)

Oxcarbazepine Oral Susp Fig-3a (Oxcarbazepine Oral Susp Fig 3a)
FDA Label Image

Oxcarbazepine Oral Susp Fig-3c (Oxcarbazepine Oral Susp Fig 3c)

Oxcarbazepine Oral Susp Fig-3c (Oxcarbazepine Oral Susp Fig 3c)
FDA Label Image

Oxcarbazepine Oral Susp Figure 4. (Oxcarbazepine Oral Susp Fig 4)

Oxcarbazepine Oral Susp Figure 4. (Oxcarbazepine Oral Susp Fig 4)
FDA Label Image

Oxcarbazepine Oral Susp Fig-4c (Oxcarbazepine Oral Susp Fig 4c)

Oxcarbazepine Oral Susp Fig-4c (Oxcarbazepine Oral Susp Fig 4c)
FDA Label Image

Oxcarbazepine Oral Susp Fig-5c (Oxcarbazepine Oral Susp Fig 5c)

Oxcarbazepine Oral Susp Fig-5c (Oxcarbazepine Oral Susp Fig 5c)
FDA Label Image

Oxcarbazepine Oral Susp Fig-6c (Oxcarbazepine Oral Susp Fig 6c)

Oxcarbazepine Oral Susp Fig-6c (Oxcarbazepine Oral Susp Fig 6c)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.